von Willebrand factor propeptide‐to‐antigen ratio in HIV‐infected pregnancy: Evidence of endothelial activation-Reference-Cited by-同舟云学术

von Willebrand factor propeptide‐to‐antigen ratio in HIV‐infected pregnancy: Evidence of endothelial activation

Published:2021-08-27 Issue:12 Volume:19 Page:3168-3176
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Schapkaitz Elise¹^ORCID,Libhaber Elena²,Jacobson Barry F.¹,Meiring Muriel³,Büller Harry R.⁴

Affiliation:

1. Department of Molecular Medicine and Hematology Charlotte Maxeke Johannesburg Academic Hospital National Health Laboratory System Complex and University of Witwatersrand Johannesburg South Africa

2. Department of Research Methodology and Statistics Faculty of Health Sciences University of Witwatersrand Medical School Johannesburg South Africa

3. Department of Hematology and Cell Biology University of Free State and National Health Laboratory Service Bloemfontein South Africa

4. Department of Vascular Medicine Academic Medical Centre University of Amsterdam the Netherlands

Funder

National Research Foundation

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15502

Reference47 articles.

1. Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy

2. Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis

3. Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy

4. Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study

5. Venous thromboembolism in HIV-positive women during puerperium: a case series

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics of the blood plasma proteome during hyperacute HIV-1 infection;2024-05-01

2. Pregnancy Related Venous Thromboembolism-Associated with HIV Infection and Antiretroviral Therapy;Seminars in Thrombosis and Hemostasis;2022-09-02

3. Evaluation of markers of fibrinolysis and coagulation in pregnant women with human immunodeficiency virus;Thrombosis Research;2022-09